Infectious Disease

Pathogens, stewardship and the response to emerging threats.

Cephalexin Label Expands Use Across Common Bacterial Infections

Updated cephalexin labeling details indications, renal dose adjustment, hypersensitivity warnings, and key drug interactions for common bacterial infections.

By Dr. A.R. Athira, MBBS · Oct 22, 2026 · 6 min read

Infectious Disease·Nat Rev Onc

Electronic health record model predicts positive blood cultures at 2 hours

A machine-learning model using electronic health record data identified pathogen-positive blood cultures two hours after ordering with moderate…

Oct 21, 2026

Infectious Disease·JNCI

Linezolid Restrictions in VRE Study Examines Stewardship and Mortality

A quasi-experimental JNCI study examines linezolid restrictions in vancomycin-resistant Enterococcus, with focus on stewardship, resistance, and mortality.

Oct 21, 2026

Infectious Disease·JNCI

tRNA-derived fragments enter dengue pathogenesis research through RNA-seq analysis

A dengue study examines tRNA-derived fragments with RNA-seq and functional characterization, probing how small RNAs may shape viral…

Oct 21, 2026

Infectious Disease·EHJ

Dengue virus infection drives rising burden and urgent fluid management needs

Dengue affects about 100 million people yearly, with no antiviral therapy available and supportive care centered on monitoring…

Oct 21, 2026

Infectious Disease·CDC

MERS Genomic Surveillance Maps Global Clade Spread Across 2012–2025

A global genomic surveillance analysis of MERS coronavirus tracks phylogenetic clades across 2012–2025 and informs outbreak monitoring and…

Oct 21, 2026

Infectious Disease·WHO

Bundibugyo Ebolavirus Outbreak in Uganda and DRC Reaches Record Size

Bundibugyo ebolavirus resurged in eastern DRC and Uganda, with rising cases, high mortality, conflict-related spread, and major gaps…

Oct 21, 2026

Infectious Disease·DailyMed

Sulfamethoxazole and Trimethoprim Label Details Spectrum, Risks, and PK

DailyMed’s updated label for sulfamethoxazole and trimethoprim reviews spectrum, pharmacokinetics, contraindications, and serious safety risks.

Oct 21, 2026

Infectious Disease·Cancer Cell

Antibacterial Immunotherapy Gains Ground Against Antimicrobial Resistance

A 2026 review examines antibacterial immunotherapy, from monoclonal antibodies to host-directed strategies, for multidrug-resistant infections.

Oct 21, 2026

Infectious Disease·PLOS Med

Rabies biosafety review maps PrEP, PEP, and lab exposure risks

PLOS synthesis compares rabies PrEP, PEP, biosafety practices, and virus inactivation evidence across species and laboratory settings.

Oct 21, 2026

Infectious Disease

Pathogens, stewardship and the response to emerging threats.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.